DexCom Inc. (DXCM)
NASDAQ: DXCM
· Real-Time Price · USD
83.28
1.29 (1.57%)
At close: Jun 16, 2025, 3:59 PM
83.23
-0.06%
After-hours: Jun 16, 2025, 06:25 PM EDT
1.57% (1D)
Bid | 83 |
Market Cap | 32.65B |
Revenue (ttm) | 4.15B |
Net Income (ttm) | 535.2M |
EPS (ttm) | 1.33 |
PE Ratio (ttm) | 62.62 |
Forward PE | 32.61 |
Analyst | Buy |
Ask | 83.46 |
Volume | 2,220,922 |
Avg. Volume (20D) | 3,993,334 |
Open | 82.80 |
Previous Close | 81.99 |
Day's Range | 82.27 - 83.68 |
52-Week Range | 57.52 - 117.91 |
Beta | 1.46 |
About DXCM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DXCM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DXCM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-0.23%
Shares of diabetes stocks are trading lower follow...
Unlock content with
Pro Subscription
2 months ago
+0.69%
Dexcom shares are trading higher after the company received FDA clearance for its G7 15-day continuous glucose monitoring system.